582 related articles for article (PubMed ID: 11934224)
1. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems.
Lestin M; Hergert M; Lestin HG; Brinker C; Storm H; Kuhrt E; Kuhrt B; Lambrecht HG; Kühnel W
Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224
[TBL] [Abstract][Full Text] [Related]
2. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction.
Eggers KM; Oldgren J; Nordenskjöld A; Lindahl B
Am Heart J; 2004 Oct; 148(4):574-81. PubMed ID: 15459585
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a proposed panel of cardiac markers for the diagnosis of acute myocardial infarction in patients with atraumatic chest pain.
Chang CC; Ip MP; Hsu RM; Vrobel T
Arch Pathol Lab Med; 1998 Apr; 122(4):320-4. PubMed ID: 9648898
[TBL] [Abstract][Full Text] [Related]
5. Clinical performance of the new cardiac markers troponin T and CK-MB on the Elecsys 2010. A multicentre evaluation.
Klein G; Kampmann M; Baum H; Rauscher T; Vukovic T; Hallermayer K; Rehner H; Müller-Bardorff M; Katus HA
Wien Klin Wochenschr; 1998; 110 Suppl 3():40-51. PubMed ID: 9677671
[TBL] [Abstract][Full Text] [Related]
6. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction.
Kost GJ; Kirk JD; Omand K
Arch Pathol Lab Med; 1998 Mar; 122(3):245-51. PubMed ID: 9823862
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria.
Collinson PO; Gaze DC; Morris F; Morris B; Price A; Goodacre S
Ann Clin Biochem; 2006 Jul; 43(Pt 4):273-80. PubMed ID: 16824277
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic utility of CK, CK-MB (activity and mass), troponin T and troponin I in patients with suspected acute myocardial infarction.
Hawkins RC; Tan HL
Singapore Med J; 1999 Nov; 40(11):680-4. PubMed ID: 10709404
[TBL] [Abstract][Full Text] [Related]
9. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction.
Wu AH; Feng YJ; Contois JH; Pervaiz S
Ann Clin Lab Sci; 1996; 26(4):291-300. PubMed ID: 8800429
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
[TBL] [Abstract][Full Text] [Related]
11. Analytical performance of time-resolved fluorometry-based Innotrac Aio! cardiac marker immunoassays.
Hedberg P; Valkama J; Puukka M
Scand J Clin Lab Invest; 2003; 63(1):55-64. PubMed ID: 12729070
[TBL] [Abstract][Full Text] [Related]
12. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.
Bar-Or D; Winkler JV; Vanbenthuysen K; Harris L; Lau E; Hetzel FW
Am Heart J; 2001 Jun; 141(6):985-91. PubMed ID: 11376314
[TBL] [Abstract][Full Text] [Related]
13. Imprecision of cardiac marker analyses among laboratories on the basis of external quality assurance results: Finnish experience.
Penttilä IM; Laatikainen A; Penttilä K; Punnonen K; Rantanen T; Savolainen K; Tiikkainen U
Scand J Clin Lab Invest; 2007; 67(5):507-18. PubMed ID: 17763187
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass.
Weber M; Rau M; Madlener K; Elsaesser A; Bankovic D; Mitrovic V; Hamm C
Clin Biochem; 2005 Nov; 38(11):1027-30. PubMed ID: 16125162
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
[TBL] [Abstract][Full Text] [Related]
16. [Serum markers for ischemic myocardial damage].
Fontes JP; Gonçalves M; Ribeiro VG
Rev Port Cardiol; 1999 Dec; 18(12):1129-36. PubMed ID: 10661020
[TBL] [Abstract][Full Text] [Related]
17. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of chemiluminescence immunoassays for detecting thyroglobulin (Tg) and thyroid peroxidase (TPO) autoantibodies using the IMMULITE 2000 system.
Bohuslavizki KH; vom Baur E; Weger B; Krebs C; Saller B; Wetlitzky O; Musiol N; Kühnel W; Lambrecht HG; Clausen M
Clin Lab; 2000; 46(1-2):23-31. PubMed ID: 10745978
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction].
Xiao HG; Huang ZH; Liu HX; Lin YP
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):550-1. PubMed ID: 15897132
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome.
Saadeddin SM; Habbab MA; Siddieg HH; Al Seeni MN; Tahery AB; Dafterdar RM
Saudi Med J; 2003 Oct; 24(10):1092-7. PubMed ID: 14578975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
